1. US Food and Drug Administration. Guidance for industry, PAT—a framework for innovative pharmaceutical development, manufacturing, and quality assurance. 2004. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070305.pdf . Accessed on 21 Oct 21.
2. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline-Pharmaceutical Quality System Q10. 2005. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q10/Step4/Q10_Guideline.pdf . Accessed on 21 Oct 2014.
3. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline-Quality Risk Management Q9. 2005. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q9/Step4/Q9_Guideline.pdf . Accessed on 21 Oct 2014.
4. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline-Pharmaceutical Development Q8 (R2). 2009. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf . Accessed on 21 Oct 2014.
5. Cogdill RP, Knight TP, Anderson CA, Drennen III JK. The financial returns on investments in process analytical technology and lean manufacturing: benchmarks and case study. J Pharm Innov. 2007;2:38–50.